CSC a site for first Crigler-Najjar gene therapy clinical trial in the world
Posted on February 16, 2018
As we strive to stay at the forefront of medical innovation and revolutionary therapies for complex genetic disorders, Clinic for Special Children becomes an important site for the first gene therapy clinical trial for Crigler-Najjar Syndrome in the world.
“From Blue Lights to Gene Therapy: The Intriguing History of Crigler-Najjar Syndrome” talks about the Clinic for Special Children’s role in this piece of medical history.